K C Lakshmaiah - Concepedia

Author

K C Lakshmaiah

Also Known As

A Piperno, K C Lakshmaiah, K Lakshmaiah, K. C. Lakshmaiah, K. Lakshmaiah, K.C. Lakshmaiah, KC Lakshmaiah, Kuntegowdanahalli C Lakshmaiah, Kuntegowdanahalli C. Lakshmaiah, Kuntegowdanahalli Chinnagiriyappa Lakshmaiah

Publications

718

Citations

H-Index

Concepts

All Affiliations

Kidwai Memorial Institute of Oncology Cancer Institute (WIA)Amgen (United States)Gdańsk Medical University

About

K C Lakshmaiah is an author at Kidwai Memorial Institute of Oncology specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	381
2	Pathology	4	4	316
3	Gastroenterology	2	2	41
4	Health Sciences	1	1	16
5	Pharmacology	1	1	16

K C Lakshmaiah

Publications

684

Citations

H-Index

Page 1

	Year	Citations
Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study Timothy Iveson, Ross C. Donehower, S. Tjulandin, The Lancet Oncology Gastrointestinal OncologyMedicinePathologyFirst-line TreatmentPharmacotherapy	2014	260
Delays in diagnosis and treatment of breast cancer: a multinational analysis Jacek Jassem, Vahit Özmen, Florin Bacanu, European Journal of Public Health	2013	145
Febrile Neutropenia in Hematological Malignancies: Clinical and Microbiological Profile and Outcome in High Risk Patients K C Lakshmaiah, Abhayakumar S Malabagi, Rachan Shetty, Journal of Laboratory Physicians	2015	52
Trebananib (AMG 386) plus weekly paclitaxel with or without bevacizumab as first-line therapy for HER2-negative locally recurrent or metastatic breast cancer: A phase 2 randomized study Véronique Dièras, Hans Wildiers, Jacek Jassem, The Breast Metastatic Breast CancerBreast OncologyMedicineAmg 386Weekly Paclitaxel	2015	49
Clinicopathological Profile of Pure Neuroendocrine Neoplasms of the Esophagus: A South Indian Center Experience Govind Babu Kanakasetty, L. Dasappa, K C Lakshmaiah, Journal of Oncology Esophageal CancerGastroenterologyPathologyEndocrine OncologyOncology	2016	27
Multiple myeloma: Experience of an institute in limited resource setting Linu Abraham Jacob, M. Babu, K C Lakshmaiah, Indian Journal of Cancer	2017	23
Correlation of BMI with breast cancer subtype and tumour size K. Govind Babu, Abhishek Anand, K C Lakshmaiah, ecancermedicalscience	2018	19
Randomized, open-label phase II study of motesanib or bevacizumab in combination with paclitaxel and carboplatin (P/C) for advanced nonsquamous non-small cell lung cancer (NSCLC). G. R. Blumenschein, Fairooz F. Kabbinavar, Hari Menon, Journal of Clinical Oncology Motesanib BidCardiovascular PharmacologyPharmacotherapySmall Molecule AntagonistOncology	2010	16
Induction chemotherapy in locally advanced T4b oral cavity squamous cell cancers: A regional cancer center experience A. H. Rudresha, Tamojit Chaudhuri, K C Lakshmaiah, Indian Journal of Cancer	2017	16
Neurofibromatosis type I with breast cancer: not only for women! K C Lakshmaiah, Anil Kumar, Samit Purohit, Hereditary Cancer in Clinical Practice Neuro-oncologyTumoral PathologyBreast OncologyMedicineSurgical Pathology	2014	15

Page 1